Related by context. Frequent words. (Click for all words.) 66 Sym# 66 radiolabeled 65 LY# [003] 65 thymalfasin 65 LY# [002] 65 Azedra 65 luteinizing hormone releasing 65 ZD# [001] 64 BMS # 64 Phase Ib clinical 64 BAY #-# 64 orally bioavailable 64 SRT# [003] 64 Irinotecan 64 Carfilzomib 63 Bortezomib 63 glatiramer acetate 63 teriparatide 63 SPC# [001] 63 intravenously administered 63 anticancer compound 63 tanespimycin 62 angiogenesis inhibitor 62 pertuzumab 62 nitazoxanide 62 Phase 2a trial 62 immunomodulator 62 mirtazapine 62 Combination therapy 62 Linaclotide 62 tocilizumab 62 HCV protease inhibitor 61 Aurora kinase 61 Trastuzumab 61 ISIS # 61 partial agonist 61 DB# [003] 61 phase IIa 61 MNTX 61 CR# vcMMAE 61 Bevacizumab 60 decitabine 60 MF# [002] 60 temsirolimus 60 Voreloxin 60 PROMACTA 60 muraglitazar 60 phase IIb 60 synthetic peptide 60 #ME# 60 CA4P 60 tipranavir 60 Monoclonal Antibody 60 mycophenolate mofetil 60 DAVANAT 60 immunomodulatory 60 prodrug 60 Cyclosporine 60 Elesclomol 60 AVE# 60 amphotericin B 60 humanized monoclonal antibody 60 Laquinimod 60 Phase IIa trial 60 MLN# 60 CGEN # 60 photodynamic therapy PDT 60 tolvaptan 60 adecatumumab 60 Phase 1b clinical 60 SCH # 60 Phase 1b trial 60 sitagliptin 60 peroxisome proliferator activated 60 RSD# 60 Imprime PGG 60 calcitonin 60 rNAPc2 60 irbesartan 60 GV# [001] 59 TYKERB 59 safinamide 59 Debio 59 potent inhibitor 59 Hycamtin 59 Preclinical studies 59 Pivotal Phase III 59 Bupropion 59 EZN 59 febuxostat 59 ALN TTR# 59 antitumor 59 diabetic neuropathic pain 59 vitro experiments 59 MBX 59 Lenalidomide 59 administered subcutaneously 59 double blinded placebo 59 KNS # 59 darinaparsin 59 topical formulation